Juno Therapeutics Inc. buy melinda
Start price
06.12.17
/
50%
€48.38
Target price
20.12.17
€55.92
Performance (%)
-17.88%
End price
20.12.17
€39.73
Summary
This prediction ended on 20.12.17 with a price of €39.73. The price of Juno Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.88%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Juno Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.463% | -1.530% | 9.993% | 57.238% |
| iShares Nasdaq 100 | -1.792% | -5.385% | -0.879% | 77.244% |
| iShares Nikkei 225® | 5.124% | 8.053% | 30.035% | 65.694% |
| iShares S&P 500 | -1.760% | -3.821% | -0.209% | 53.468% |
Comments by melinda for this prediction
In the thread Juno Therapeutics Inc. diskutieren
2017.11.12 Die aktualisierten Daten aus Phase 1 werden 11, bei ASH Dezember 2017 vorgelegt werden.
r / r Non-Hodgkin-B-Zell - Lymphom - Krebs
Phase 1/2
(Vom Mitglied beendet)
Stopped prediction by melinda for Juno Therapeutics Inc.
Juno Therapeutics Inc.
Start price
Target price
Perf. (%)
€43.69
05.01.18
05.01.18
€56.38
17.01.18
17.01.18
39.54%
17.01.18
17.01.18
Juno Therapeutics Inc.
Start price
Target price
Perf. (%)
€27.85
14.07.16
14.07.16
€44.20
16.01.17
16.01.17
-35.22%
16.01.17
16.01.17